Common TitlePROTON
Official Title Sofosbuvir in Combination with Peginterferon alfa-2a and Ribavirin for Non-cirrhotic, Treatment-naive Patients with Genotypes 1, 2, and 3 Hepatitis C Infection: A Randomised, Double-Blind, Phase 2 Trial.
Phase Phase II
ClinicalTrials.gov NCT01188772
Treatments
Sofosbuvir

Sofosbuvir
Tradename:SovaldiOther Names:SOFClass:FDA-ApprovedFunding
IndustryGilead Sciences